Showing 1 - 9 results of 9 for search 'Jan de Hoon', query time: 0.05s Refine Results
  1. 1
    Renal Side Effects of Non-Steroidal Anti-Inflammatory Drugs in Neonates

    Renal Side Effects of Non-Steroidal Anti-Inflammatory Drugs in Neonates by Marc Gewillig, Anne Debeer, Jan de Hoon, Karel Allegaert

    Published 2010
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Effective analgesia after cesarean delivery needs pharmacokinetic input

    Effective analgesia after cesarean delivery needs pharmacokinetic input by Aida Kulo, Jan de Hoon, Nedzad Mulabegovic, Karel Allegaert

    Published 2012
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Simultaneous Semi-Mechanistic Population Pharmacokinetic Modeling Analysis of Enalapril and Enalaprilat Serum and Urine Concentrations From Child Appropriate Orodispersible Minitablets

    Simultaneous Semi-Mechanistic Population Pharmacokinetic Modeling Analysis of Enalapril and Enalaprilat Serum and Urine Concentrations From Child Appropriate Orodispersible Minitab... by Muhammad Faisal, Willi Cawello, Bjoern B. Burckhardt, Jan de Hoon, Stephanie Laer, LENA Consortium

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    The New First-in-Human EMA Guideline: Disruptive or Constructive? Outcomes From the First EUFEMED Discussion Forum

    The New First-in-Human EMA Guideline: Disruptive or Constructive? Outcomes From the First EUFEMED Discussion Forum by Kerstin Breithaupt-Grögler, Tim Hardman, Tim Hardman, Jan de Hoon, Yves Donazzolo, Sylvie Rottey, Hildegard Sourgens, Steffan Stringer

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    First‐in‐human development of a pharmacodynamic biomarker for PAC1 receptor antagonists using intradermal injections of maxadilan

    First‐in‐human development of a pharmacodynamic biomarker for PAC1 receptor antagonists using intradermal injections of maxadilan by Heleen Marynissen, Linde Buntinx, Dorien Bamps, Marleen Depre, Els Ampe, Anne Van Hecken, Kristin Gabriel, Steve Sands, Gabriel Vargas, Jan de Hoon

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management

    EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management by Luc Van Bortel, Hildegard Sourgens, Kerstin Breithaupt-Grögler, Henri Caplain, Yves Donazzolo, Ingrid Klingmann, Michael Hammond, Timothy C. Hardman, Steffan Stringer, Jan de Hoon

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers

    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers by David Monteith, David Monteith, Emily C. Collins, Corinne Vandermeulen, Anne Van Hecken, Eyas Raddad, Joel C. Scherer, David Grayzel, Thomas J. Schuetz, Jan de Hoon

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Pharmacokinetic and pharmacodynamic assessments of atogepant in healthy male adults: Results from phase 1 studies

    Pharmacokinetic and pharmacodynamic assessments of atogepant in healthy male adults: Results from phase 1 studies by Ramesh Boinpally, Marleen Depré, Griet Van Lancker, Marissa F Dockendorf, Phung Bondiskey, Jean-Francois Denef, Tom Reynders, Catherine Zhou Matthews, K Chris Min, Jialin Xu, Joel M Trugman, Jan de Hoon

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    SDI-118, a novel procognitive SV2A modulator: First-in-human randomized controlled trial including PET/fMRI assessment of target engagement

    SDI-118, a novel procognitive SV2A modulator: First-in-human randomized controlled trial including PET/fMRI assessment of target engagement by Wouter Botermans, Michel Koole, Koen Van Laere, Jonathan R. Savidge, John A. Kemp, Stefan Sunaert, Maeve M. Duffy, Steven Ramael, Andrea M. Cesura, Kevin D'Ostilio, Denis Gossen, Torsten M. Madsen, Thomas Lodeweyckx, Jan de Hoon

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: